TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 8,756 | 9,467 | 9,705 |
Financial expenses | 1 | 27 | 28 |
Earnings before taxes | -448 | 472 | 1,467 |
EBITDA | -431 | 530 | 1,543 |
Total assets | 4,727 | 4,390 | 4,780 |
Current assets | 4,667 | 4,308 | 4,663 |
Current liabilities | 2,408 | 1,380 | 2,114 |
Equity capital | 2,022 | 2,606 | 2,279 |
- share capital | 9 | 10 | 10 |
Employees (average) | 65 | 57 | 62 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 42.8% | 59.4% | 47.7% |
Turnover per employee | 135 | 166 | 157 |
Profit as a percentage of turnover | -5.1% | 5.0% | 15.1% |
Return on assets (ROA) | -9.5% | 11.4% | 31.3% |
Current ratio | 193.8% | 312.2% | 220.6% |
Return on equity (ROE) | -22.2% | 18.1% | 64.4% |
Change turnover | 57 | -59 | 1,217 |
Change turnover % | 1% | -1% | 14% |
Chg. No. of employees | 8 | -5 | 1 |
Chg. No. of employees % | 14% | -8% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.